CSIMarket
 


Nutriband Inc   (NTRB)
Other Ticker:  
 
 

NTRB's Net Income Growth by Quarter and Year

Nutriband Inc 's Net Income results by quarter and year




NTRB Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter January - -1.57 -0.04 -0.75
III Quarter October -1.08 -0.52 -0.23 -0.57
II Quarter July -1.04 -0.32 -0.41 -0.57
I Quarter April -0.69 -2.04 -0.82 -0.52
FY   -2.81 -4.45 -1.50 -2.41



NTRB Net Income third quarter 2023 Y/Y Growth Comment
Nutriband Inc in the third quarter 2023 recorded net loss of $ -1.08 millions.

According to the results reported in the third quarter 2023, Nutriband Inc achieved the best Net Income growth in Biotechnology & Pharmaceuticals industry. While Nutriband Inc ' s Net Income no change of % ranks overall at the positon no. in the third quarter 2023.




NTRB Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter January - - - -
III Quarter October - - - -
II Quarter July - - - -
I Quarter April - - - -
FY   - - - -

Financial Statements
Nutriband Inc 's third quarter 2023 Net Income $ -1.08 millions NTRB's Income Statement
Nutriband Inc 's third quarter 2022 Net Income $ -0.52 millions Quarterly NTRB's Income Statement
New: More NTRB's historic Net Income Growth >>


NTRB Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter January - - - -
III Quarter October - - - -
II Quarter July - - - -
I Quarter April - - - -
FY (Year on Year)   - - - -




Net Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Nutriband Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NTRB's III. Quarter Q/Q Net Income Comment
Recent net loss of -1.08 millions by Nutriband Inc appear even worse considering the -1.04 millions in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Nutriband Inc achieved highest sequential Net Income growth. While Nutriband Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


NTRB's III. Quarter Q/Q Net Income Comment
III. Quarter 2023 results of -1.08 millions by Nutriband Inc appear even worse if you take a look at net loss -1.04 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Nutriband Inc achieved highest sequential Net Income growth. While Nutriband Inc 's Net Income growth quarter on quarter, overall rank is .


Nutriband Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Oct 31 2022)
12 Months Ending
(Jul 31 2022)
12 Months Ending
(Apr 30 2022)
12 Months Ending
(Oct 31 2021)
12 Months Ending
(Jul 31 2021)
Cumulative Net Income 12 Months Ending $ -4.38 $ -3.82 $ -3.10 $ -4.45 $ -2.92
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Nutriband Inc ' has realized cumulative trailing twelve months net loss of $ -4 millions in the Oct 31 2022 period.
The results are detiriorating as the cumulative net loss is inflating from $ -3.82 millions for the period from Jul 31 2022 to Jul 31 2021 and $ -1.04 millions for the twelve months ending in the quarter a year ago Christian Brown wrote.

Nutriband Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Nutriband Inc ' has realized cumulative trailing twelve months net loss of $ -4 millions in the Oct 31 2022 period.
The results are getting worse as the cumulative net loss is getting bigger from $ -3.82 millions for the period from Jul 31 2022 to Jul 31 2021 and $ -1.04 millions for the twelve months ending in the quarter Jul 31 2021 Christian Brown mentioned.

Nutriband Inc achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Pharmaceuticals Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
NTRB's Net Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for NTRB's Competitors
Net Income Growth for Nutriband Inc 's Suppliers
Net Income Growth for NTRB's Customers

You may also want to know
NTRB's Annual Growth Rates NTRB's Profitability Ratios NTRB's Asset Turnover Ratio NTRB's Dividend Growth
NTRB's Roe NTRB's Valuation Ratios NTRB's Financial Strength Ratios NTRB's Dividend Payout Ratio
NTRB's Roa NTRB's Inventory Turnover Ratio NTRB's Growth Rates NTRB's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Oct 31 2022 within Healthcare SectorY/Y Change %Net Income for the quarter ending Oct 31 2022
Haemonetics Corporation123.46%$ 123.459 millions
Avnet Inc 65.53%$ 65.527 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CANG's Profile

Stock Price

CANG's Financials

Business Description

Fundamentals

Charts & Quotes

CANG's News

Suppliers

CANG's Competitors

Customers & Markets

Economic Indicators

CANG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071